NCT06208124 2025-05-28
A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors
Immuneering Corporation
Phase 1/2 Completed
Immuneering Corporation
Universitaire Ziekenhuizen KU Leuven
University Hospital, Essen
Catalysis SL
Fox Chase Cancer Center
Ruhr University of Bochum